Becton, Dickinson and Company’s fourth quarter results were shaped by ongoing portfolio transformation, targeted investments ...

BD (NYSE: BDX) shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...

Company’s latest solutions are designed to empower healthcare providers across the Middle East region, strengthen patient ...

Waters has announced the completion of its acquisition of BD’s Biosciences and Diagnostic Solutions businesses.

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect.

Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...

Earlier this year, BD revealed its intent to split from its lifesciences and diagnostic solutions business to become a pure-play medical device company. On the surface, medtech analysts have largely ...